Enantioconvergent synthesis of a promising HMG CoA reductase inhibitor NK-104 from both enantiomers of epichlorohydrin
- 28 February 1993
- journal article
- research article
- Published by Elsevier in Tetrahedron: Asymmetry
- Vol. 4 (2) , 201-204
- https://doi.org/10.1016/s0957-4166(00)82337-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A novel enantioselective synthesis of HMG Co-A reductase inhibitor NK-104 and a related compoundTetrahedron Letters, 1992
- Stereocontrolled route to the δ-benzylidenemethyl-β-hydroxy-δ-lactone system utilizing a new chiral epoxyacetylene building blockTetrahedron: Asymmetry, 1992
- Enantioselective synthesis of .beta.-hydroxy .delta.-lactones: a new approach to the synthetic congeners of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsThe Journal of Organic Chemistry, 1991
- Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductaseJournal of Medicinal Chemistry, 1991
- Chapter 16. Treatment of HypercholesterolemiaPublished by Elsevier ,1989
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipolJAMA, 1987
- Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductaseJournal of Medicinal Chemistry, 1985
- 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. I. Structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivativesJournal of Medicinal Chemistry, 1985
- A convenient method for the synthesis of 5′-S-alkylthio-5′-deoxyribonucleosidesTetrahedron Letters, 1975